• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 4'-methyl-1,1'-bi(cyclohexyl)-4-one (CAS No. 151772-66-6)

4'-methyl-1,1'-bi(cyclohexyl)-4-one, identified by its Chemical Abstracts Service (CAS) number 151772-66-6, is a significant compound in the realm of organic chemistry and pharmaceutical research. This bicyclic ketone derivative has garnered attention due to its unique structural properties and potential applications in synthetic chemistry and drug development. The compound consists of two cyclohexyl rings linked by a ketone group, with a methyl substituent at the 4' position, which contributes to its distinct chemical behavior and reactivity.

The molecular structure of 4'-methyl-1,1'-bi(cyclohexyl)-4-one exhibits a rigid framework due to the cyclohexane rings, which can influence its interactions with biological targets. This rigidity makes it a valuable scaffold for designing molecules with specific pharmacological properties. The presence of the ketone group introduces polarity to the molecule, enabling hydrogen bonding interactions, while the methyl group at the 4' position further modulates electronic distribution and steric hindrance.

In recent years, there has been growing interest in exploring the pharmacological potential of bicyclic ketones. These compounds have shown promise as intermediates in the synthesis of bioactive molecules, particularly in the development of central nervous system (CNS) drugs. The structural motif of 4'-methyl-1,1'-bi(cyclohexyl)-4-one resembles certain natural products and pharmacophores that exhibit neuroprotective, anti-inflammatory, and analgesic effects. This has prompted researchers to investigate its derivatives as candidates for therapeutic intervention.

One of the most compelling aspects of 4'-methyl-1,1'-bi(cyclohexyl)-4-one is its versatility in synthetic chemistry. The compound can serve as a building block for more complex molecules through various functionalization strategies. For instance, nucleophilic addition reactions at the ketone group can yield alcohols or amides, while Friedel-Crafts acylations can introduce additional substituents. These reactions are fundamental in medicinal chemistry and enable the creation of libraries of compounds for high-throughput screening.

Recent studies have highlighted the role of bicyclic structures in drug design due to their ability to mimic natural product scaffolds and enhance binding affinity to biological targets. The cyclohexane rings in 4'-methyl-1,1'-bi(cyclohexyl)-4-one provide a stable core that can be further modified to optimize pharmacokinetic and pharmacodynamic properties. This has led to investigations into its derivatives as potential treatments for neurological disorders, including Alzheimer's disease and Parkinson's disease.

The synthesis of 4'-methyl-1,1'-bi(cyclohexyl)-4-one typically involves condensation reactions between cyclohexanone derivatives and appropriate alkylating agents. Advances in catalytic methods have improved the efficiency and selectivity of these reactions, making it more feasible to produce this compound on a larger scale. Such improvements are crucial for pharmaceutical applications where high purity and yield are essential.

In addition to its synthetic utility, 4'-methyl-1,1'-bi(cyclohexyl)-4-one has been studied for its potential role in material science. The rigid bicyclic structure can contribute to the development of polymers with specific mechanical properties. For example, incorporation into polymeric matrices can enhance thermal stability and mechanical strength. This interdisciplinary approach underscores the broad applicability of this compound beyond traditional pharmaceuticals.

Current research is exploring novel derivatives of 4'-methyl-1,1'-bi(cyclohexyl)-4-one with enhanced biological activity. By modifying substituents or introducing additional functional groups, scientists aim to develop molecules with improved efficacy and reduced side effects. Computational modeling techniques are increasingly being employed to predict the behavior of these derivatives before experimental synthesis, which accelerates the drug discovery process.

The pharmacological evaluation of bicyclic ketones has revealed intriguing interactions with various biological targets. For instance, some derivatives have shown inhibitory activity against enzymes involved in inflammatory pathways. This aligns with the growing interest in developing anti-inflammatory drugs that target specific molecular mechanisms without systemic side effects. The structural features of 4'-methyl-1,1'-bi(cyclohexyl)-4-one make it an attractive candidate for further exploration in this context.

Future directions in the study of 4'-methyl-1,1'-bi(cyclohexyl)-4-one include investigating its role in drug delivery systems. Bicyclic structures can be engineered to enhance solubility or targeted delivery to specific tissues or organs. This could lead to more effective treatments for diseases that are currently difficult to manage with existing therapies.

In conclusion, 4'-methyl-1,1'-bi(cyclohexyl)-4-one (CAS No. 151772-66-6) is a multifaceted compound with significant potential in both synthetic chemistry and pharmaceutical research. Its unique structural features make it a valuable scaffold for designing bioactive molecules with therapeutic applications across multiple domains. As research continues to uncover new derivatives and applications, this compound is poised to play an increasingly important role in advancing scientific knowledge and developing innovative solutions for complex challenges.

• 20519-71-5(Cyclohexanone,4,4'-(1,2-diethyl-1,2-ethanediyl)bis-, (R*,S*)- (9CI))
• 10534-34-6(4-4-(propan-2-yl)cyclohexylbutan-2-one)
• 69824-93-7(Cyclohexanone, 3-hexyl-)
• 342794-05-2(Cyclohexanone,3-ethyl-5-(1-methylethyl)-, (3R,5R)-rel-)
• 10036-09-6(bicyclo3.3.1nonan-3-one)
• 34131-98-1(Decatone)
• 342813-29-0(Cyclohexanone,3-methyl-5-(1-methylethyl)-, (3S,5S)-)
• 33665-35-9(Cyclohexanone, 4,4'-(1,2-diethyl-1,2-ethanediyl)bis-)
• 63307-60-8(2-Butanone, 4-(2,6-dimethylcyclohexyl)-)
• 69824-92-6(Cyclohexanone, 3-pentyl-)